United Therapeutic (UTHR) Stock Price, Quote & News

Company Profile

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated wit...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 301 608 9292

Website: www.unither.com

Address:

1000 Spring Street, Silver Spring, United States

grampslol Mar. 21 at 12:47 AM

$MNKD interesting $UTHR hypothesis @kevinmik... interesting indeed

0 · Reply

jlonards Mar. 20 at 2:07 PM

$UTHR mentally ill

1 · Reply

InTheMoney_ Mar. 19 at 10:06 PM

$UTHR $SPY CEO selling http://finshort.com/UTHR/insiders

1 · Reply

grampslol Mar. 19 at 6:54 PM

$MNKD remember the CEO of $UTHR said tyvaso dpi has coughing issues and so they're going to be going with SMI ,but there's still Afizzle... don't forget... #flopdrug #dontblameceo

0 · Reply

Bazzzigar Mar. 19 at 3:06 PM

$UTHR HIMS

0 · Reply

Harryx1 Mar. 18 at 3:16 PM

$MNKD $UTHR But he/she-that-shall-not-be-named wants you to believe that some 20+ year old technology that's been sitting on a shelf is going to be a blockbuster over Tyvaso DPI. Why didn't they go to it before if it suppose to be so great??? And why are they still going ahead with the 2nd molecule on Technosphere???

8 · Reply

Harryx1 Mar. 18 at 3:01 PM

$MNKD $UTHR They are still putting out videos praising Tyvaso DPI, I wonder why!?!?! (Because it's their BEST SELLING DRUG!!!!) https://www.youtube.com/watch?v=BFArR7MYPhg

0 · Reply

grampslol Mar. 18 at 12:57 AM

$MNKD update on $UTHR tyfizzle dpi from $MNKD , #coughcough , So uthr going SMI way $LQDA wins dpi !

0 · Reply

grampslol Mar. 17 at 3:33 PM

$MNKD poor steveio...smh...except the CEO of $UTHR says there's coughing issues with dpi hence the major Afizzle company mnkd haircut that's happened since earnings miss. #afizzle #tyfizzle #pumperslie #coughcough

0 · Reply

grampslol Mar. 17 at 2:28 PM

$MNKD $UTHR mnkd dpi tyfizzle #coughcough #smiwayoffuture

0 · Reply

United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine

Mar 11, 2026, 6:53 AM EDT - 10 days ago

United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade)

Mar 9, 2026, 3:18 PM EDT - 12 days ago

United Therapeutics Corporation (UTHR) Presents at Leerink Global Healthcare Conference 2026 Transcript

Mar 9, 2026, 7:00 AM EDT - 12 days ago

United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program

Mar 3, 2026, 7:00 AM EST - 18 days ago

United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference

Mar 2, 2026, 4:27 PM EST - 19 days ago

United Therapeutics Corporation (UTHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 2, 2026, 4:07 PM EST - 19 days ago

United Therapeutics Corporation (UTHR) Discusses Phase III ADVANCE OUTCOMES Clinical Trial Results in Pulmonary Hypertension Transcript

Mar 2, 2026, 6:38 AM EST - 19 days ago

United Therapeutics' blood pressure drug meets main, secondary goals in late-stage study

Mar 2, 2026, 6:30 AM EST - 19 days ago

United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy

Feb 26, 2026, 1:54 PM EST - 23 days ago

These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings

Feb 26, 2026, 11:30 AM EST - 23 days ago

United Therapeutics Q4 Earnings: Sky May Be The Limit For This Management Team

Feb 25, 2026, 12:07 PM EST - 24 days ago

United Therapeutics Corporation (UTHR) Q4 2025 Earnings Call Transcript

Feb 25, 2026, 6:30 AM EST - 24 days ago

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 23, 2026, 7:00 AM EST - 26 days ago

United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference

Feb 11, 2026, 7:00 AM EST - 5 weeks ago

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026

Jan 26, 2026, 7:00 AM EST - 7 weeks ago

United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure

Jan 22, 2026, 7:00 AM EST - 2 months ago

United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors

Jan 13, 2026, 2:25 AM EST - 2 months ago

United Therapeutics Corporation (UTHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 3:57 PM EST - 2 months ago

6 stocks and ETFs that these unsung market heroes see outperforming in 2026

AAPL DT GLD ITRN MNKD NVDA OMC

Jan 5, 2026, 7:00 AM EST - 2 months ago

United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 3, 2025, 7:19 AM EST - 3 months ago

Flurry of Bullish Inflows Sends United Therapeutics Higher

Nov 18, 2025, 10:38 AM EST - 4 months ago

United Therapeutics Corporation (UTHR) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 10, 2025, 2:01 PM EST - 4 months ago

United Therapeutics Corporation (UTHR) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 4, 2025, 7:00 AM EST - 4 months ago

United Therapeutics Corporation to Present at Upcoming Investor Conferences

Nov 3, 2025, 7:00 AM EST - 4 months ago

United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease

Oct 29, 2025, 12:16 PM EDT - 5 months ago

United Therapeutics Corporation (UTHR) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 6:30 AM EDT - 5 months ago

United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results

Oct 15, 2025, 7:00 AM EDT - 5 months ago

United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025

Oct 13, 2025, 7:00 AM EDT - 5 months ago

United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting

Sep 28, 2025, 5:27 PM EDT - 6 months ago

United Therapeutics Corporation - Special Call

Sep 23, 2025, 4:03 PM EDT - 6 months ago

United Therapeutics Corporation (UTHR) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript

Sep 19, 2025, 7:00 AM EDT - 6 months ago

United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis

Sep 16, 2025, 7:00 AM EDT - 6 months ago

United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum

Sep 12, 2025, 7:00 AM EDT - 6 months ago

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress

Sep 8, 2025, 5:31 PM EDT - 6 months ago

United Therapeutics Corporation (UTHR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 4, 2025, 4:26 PM EDT - 7 months ago

United Therapeutics: Nebulized Tyvaso Label Expansion Possible For IPF After Study Win

Sep 3, 2025, 10:10 AM EDT - 7 months ago

United Therapeutics: Is UTHR Stock Still A Buy At $400?

Sep 2, 2025, 10:59 AM EDT - 7 months ago

Why Is United Therapeutics Stock Rallying On Tuesday?

Sep 2, 2025, 10:09 AM EDT - 7 months ago

United Therapeutics surges as Tyvaso succeeds in IPF trial: should you invest?

Sep 2, 2025, 9:17 AM EDT - 7 months ago

United Therapeutics shares surge on successful late-stage lung disease study

Sep 2, 2025, 7:00 AM EDT - 7 months ago

United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis

Aug 29, 2025, 7:00 AM EDT - 7 months ago

United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 27, 2025, 9:53 AM EDT - 7 months ago

United Therapeutics: Critical September IPF Data Catalyst Sets Up Momentous Year

Aug 1, 2025, 7:00 AM EDT - 8 months ago

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program

Jul 30, 2025, 10:51 PM EDT - 8 months ago

United Therapeutics Corporation (UTHR) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 6:30 AM EDT - 8 months ago

United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results

Jul 16, 2025, 7:00 AM EDT - 8 months ago

United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025

Jun 24, 2025, 7:00 AM EDT - 9 months ago

United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver

Jun 23, 2025, 7:00 AM EDT - 9 months ago

United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension

Jun 11, 2025, 1:36 PM EDT - 10 months ago

United Therapeutics: Tanking On Rival's PAH Data - I'd Consider Buying Stock

grampslol Mar. 21 at 12:47 AM

$MNKD interesting $UTHR hypothesis @kevinmik... interesting indeed

0 · Reply

jlonards Mar. 20 at 2:07 PM

$UTHR mentally ill

1 · Reply

InTheMoney_ Mar. 19 at 10:06 PM

$UTHR $SPY CEO selling http://finshort.com/UTHR/insiders

1 · Reply

grampslol Mar. 19 at 6:54 PM

$MNKD remember the CEO of $UTHR said tyvaso dpi has coughing issues and so they're going to be going with SMI ,but there's still Afizzle... don't forget... #flopdrug #dontblameceo

0 · Reply

Bazzzigar Mar. 19 at 3:06 PM

$UTHR HIMS

0 · Reply

Harryx1 Mar. 18 at 3:16 PM

8 · Reply

Harryx1 Mar. 18 at 3:01 PM

$MNKD $UTHR They are still putting out videos praising Tyvaso DPI, I wonder why!?!?! (Because it's their BEST SELLING DRUG!!!!) https://www.youtube.com/watch?v=BFArR7MYPhg

0 · Reply

grampslol Mar. 18 at 12:57 AM

$MNKD update on $UTHR tyfizzle dpi from $MNKD , #coughcough , So uthr going SMI way $LQDA wins dpi !

0 · Reply

grampslol Mar. 17 at 3:33 PM

0 · Reply

grampslol Mar. 17 at 2:28 PM

$MNKD $UTHR mnkd dpi tyfizzle #coughcough #smiwayoffuture

0 · Reply

stevemano Mar. 17 at 2:11 PM

$MNKD don’t let the wicked witch of the east deceive you, Martin or whatever it is! $UTHR “United Therapeutics' outlook for Tyvaso DPI is highly positive, driven by rapid adoption, strong Q2 2025 revenue growth of 22% year-over-year to $315 million, and its position as a primary revenue engine for the company.”

0 · Reply

Brypannebecker Mar. 15 at 7:28 PM

$IBRX $MNKD $UTHR IBRX is transformational!!

0 · Reply

Outcomes Mar. 15 at 7:01 PM

$IBRX $MNKD $UTHR …I own 2 of them!

0 · Reply

BigCheeze2014 Mar. 15 at 6:00 PM

$UTHR 💩💩💩😷

0 · Reply

grampslol Mar. 14 at 8:41 AM

$MNKD poor @clan....smh...deluding himself as he tries to chump others...a sad fellow $SCPH $UTHR #afizzle

0 · Reply

clan Mar. 14 at 8:34 AM

$MNKD $UTHR $SCPH The Fix Is In!

0 · Reply

Doozio Mar. 12 at 4:24 PM

$UTHR now they are worried about oil while this gorilla is ready to bust outta da $GRDN

0 · Reply

SuperGreenToday Mar. 12 at 10:40 AM

$UTHR Share Price: $545.07 Contract Selected: Jun 18, 2026 $540 Calls Buy Zone: $35.50 – $43.85 Target Zone: $66.32 – $81.06 Potential Upside: 76% ROI Time to Expiration: 97 Days | Updates via https://fxcapta.com/stockinfo/

1 · Reply

NorthStarStats Mar. 12 at 9:23 AM

Output from a custom NorthStarStats momentum scanner highlighting stocks with strengthening price structure and momentum. Setups to watch and study — not trade recommendations. Numbers are looking a bit light for today: $MOS Score: 98.00, $MGM Score: 71.00, $ADM Score 70.00, $DAY Score 70.00, $UTHR Score 68.00

0 · Reply

kcphaeton Mar. 12 at 4:51 AM

$MNKD $UTHR @Kool_Aid_Mann something sure got Martin’s panties in a wad. i’m sure it’s not what used to be there.

0 · Reply

kcphaeton Mar. 12 at 4:49 AM

$JNJ $LLY $UTHR or something sure got Martin’s panties in a wad. i’m sure it’s not what used to be there.

0 · Reply

jlonards Mar. 12 at 2:45 AM

$UTHR $MNKD So Martin is still building a $500 million facility but now it's for TreSMI? Or, is construction on hold? What's actually on hold is approval by the FDA of approval for TreSMI. Also, where is this building and what % of construction is completed? Something smells, not right.

5 · Reply

Market Cap	22.98B
Revenue (ttm)	3.18B
Net Income (ttm)	1.33B
EPS (ttm)	N/A
PE Ratio	18.89
Forward PE	19.25
Profit Margin	41.94%
Debt to Equity Ratio	0.00

Volume	796,600
Avg Vol	441,848
Day's Range	N/A - N/A
Shares Out	43.83M
Stochastic %K	15%
Beta	0.84
Analysts	Strong Sell
Price Target	$593.08